The seroepidemiology of immunoglobulin G antibodies against pertussis toxin and filamentous hemagglutinin in the east of China during the COVID-19 pandemic

References

• Thisyakorn U, Tantawichien T, Thisyakorn C, Buchy P. Pertussis in the association of Southeast Asian Nations: epidemiology and challenges. Int J Infect Dis. 2019;87:75–7. doi:10.1016/j.ijid.2019.07.016.
   PubMed Web of Science ®Google Scholar
• Decker MD, Edwards KM. Pertussis (Whooping Cough). J Infect Dis. 2021;224(Supplement_4):S310–S320. doi:10.1093/infdis/jiaa469.
   PubMedGoogle Scholar
• Syed MA, Bana NF. Pertussis. A reemerging and an underreported infectious disease. Saudi Med J. 2014;35:1181–1187.
   PubMed Web of Science ®Google Scholar
• Williamson YM, Moura H, Whitmon J, Woolfitt AR, Schieltz DM, Rees JC, Guo S, Kirkham H, Bouck D, Ades EW, et al. A proteomic characterization of bordetella pertussis clinical isolates associated with a California state pertussis outbreak. Int J Proteomics. 2015;2015:1–12. doi:10.1155/2015/536537.
   Google Scholar
• Zhang Q, Zheng H, Liu M, Han K, Shu J, Wu C, Xu N, He Q, Luo H. The seroepidemiology of immunoglobulin G antibodies against pertussis toxin in China: a cross sectional study. BMC Infect Dis. 2012;12(1):138. doi:10.1186/1471-2334-12-138.
   PubMedGoogle Scholar
• Chen Z, Pang J, Zhang Y, Ding Y, Chen N, Zhang N, He Q. Seroprevalence of pertussis in adults at childbearing age pre- and post- COVID-19 in Beijing, China. Vaccines (Basel). 2022;10(6):10. doi:10.3390/vaccines10060872.
   Web of Science ®Google Scholar
• Merdrignac L, Aït EBF, Pandolfi E, Jané M, Murphy J, Fabiánová K, García Cenoz M, Flem E, Guillot S, Tozzi AE, et al. Incidence and severity of pertussis hospitalisations in infants aged less than 1 year in 37 hospitals of six EU/EEA countries, results of PERTINENT sentinel pilot surveillance system, December 2015 to December 2018. Euro Surveill. 2021;26. doi:10.2807/1560-7917.ES.2021.26.4.1900762.
   PubMedGoogle Scholar
• Regan AK, Moore HC, Binks MJ, McHugh L, Blyth CC, Pereira G, Lust K, Sarna M, Andrews R, Foo D, et al. Maternal pertussis vaccination, infant immunization, and risk of pertussis. Pediatrics. 2023;152(5):152. doi:10.1542/peds.2023-062664.
   Web of Science ®Google Scholar
• Somerville RL, Grant CC, Grimwood K, Murdoch D, Graham D, Jackson P, Meates‐Dennis M, Nicholson R, Purvis D. Infants hospitalised with pertussis: estimating the true disease burden. J Paediatr Child Health. 2007;43(9):617–622. doi:10.1111/j.1440-1754.2007.01154.x.
   PubMed Web of Science ®Google Scholar
• Weigand MR, Pawloski LC, Peng Y, Ju H, Burroughs M, Cassiday PK, Davis JK, DuVall M, Johnson T, Juieng P, et al. Screening and genomic characterization of filamentous hemagglutinin-deficient bordetella pertussis. Infect Immun. 2018;86(4). doi:10.1128/IAI.00869-17.
   PubMed Web of Science ®Google Scholar
• Xu Y, Wang L, Xu J, Wang X, Wei C, Luo P, Ma X, Hou Q, Wang J. Seroprevalence of pertussis in China: need to improve vaccination strategies. Hum Vaccines Immunother. 2014;10(1):192–198. doi:10.4161/hv.26335.
   PubMed Web of Science ®Google Scholar
• He H, Zhu Y, Jin M, Zhou Y, Tang X, Yan R, Deng X, Chen K. The decline in immunity and circulation of pertussis among Chinese population during the COVID-19 pandemic: a cross-sectional sero-epidemiological study. Vaccine. 2022;40(48):6956–6962. doi:10.1016/j.vaccine.2022.10.020.
   PubMed Web of Science ®Google Scholar
• Wu Y, Cheng Q, Guo H. IgG antibody levels against pertussis toxin and filamentous hemagglutinin among healthy people of Jiangsu province in 2018. Chin J Vaccines Immun. 2020;26:173–176.
   Google Scholar
• Huang HT, Gao ZG, Liu Y, Wang LJ, Liu YP, Zhang Y. Epidemiological characteristics and risk factors of the pertussis in infants <12 months of age in Tianjin, China. Biomed Environ Sci. 2017;30:545–548.
   PubMed Web of Science ®Google Scholar
• Liu TC, Zhang J, Liu SQ, Yin AT, Ruan SM. Evaluation of immunisation strategies for pertussis vaccines in Jinan, China – an interrupted time-series study. Epidemiol Infect. 2020;148:e26. doi:10.1017/S0950268820000102.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Yin Z, Li Y, Luo H, Shao Z, Gao Y, Xu L, Kan B, Lu S, Zhang Y, et al. Prevalence of asymptomatic bordetella pertussis and bordetella parapertussis infections among school children in China as determined by pooled real-time PCR: a cross-sectional study. Scand J Infect Dis. 2014;46(4):280–287. doi:10.3109/00365548.2013.878034.
   PubMed Web of Science ®Google Scholar
• Scott S, van der Sande M, Faye-Joof T, Mendy M, Sanneh B, Barry Jallow F, de Melker H, van der Klis F, van Gageldonk P, Mooi F, et al. Seroprevalence of pertussis in the Gambia: evidence for continued circulation of bordetella pertussis despite high vaccination rates. Pediatr Infect Dis J. 2015;34(4):333–338. doi:10.1097/INF.0000000000000576.
   PubMed Web of Science ®Google Scholar
• Rodríguez DLPM, Castro LM, Ramon TJ, García de Lomas J, Devadiga R, Reyes J, McCoig C, Tafalla M, García-Corbeira P. Seroprevalence of pertussis amongst healthcare professionals in Spain. Vaccine. 2016;34:1109–1114. doi:10.1016/j.vaccine.2015.12.036.
   PubMed Web of Science ®Google Scholar
• Campins-Martí M, Cheng HK, Forsyth K, Guiso N, Halperin S, Huang L-M, Mertsola J, Oselka G, Ward J, Wirsing von König CH, et al. Recommendations are needed for adolescent and adult pertussis immunisation: rationale and strategies for consideration. Vaccine. 2001;20(5–6):641–646. doi:10.1016/S0264-410X(01)00393-0.
   PubMed Web of Science ®Google Scholar
• de Melker HE, Versteegh FG, Schellekens JF, TEUNIS P, KRETZSCHMAR M. The incidence of bordetella pertussis infections estimated in the population from a combination of serological surveys. J Infect. 2006;53:106–113. doi:10.1016/j.jinf.2005.10.020.
   PubMed Web of Science ®Google Scholar
• Lai FY, Thoon KC, Ang LW, Tey SH, Heng D, Cutter JL, Phoon MC, Chow VT. Comparative seroepidemiology of pertussis, diphtheria and poliovirus antibodies in Singapore: waning pertussis immunity in a highly immunized population and the need for adolescent booster doses. Vaccine. 2012;30(24):3566–3571. doi:10.1016/j.vaccine.2012.03.059.
   PubMed Web of Science ®Google Scholar
• Campbell PT, McCaw JM, McIntyre P, McVernon J. Defining long-term drivers of pertussis resurgence, and optimal vaccine control strategies. Vaccine. 2015;33:5794–5800. doi:10.1016/j.vaccine.2015.09.025.
   PubMed Web of Science ®Google Scholar
• Chiu TF, Lee CY, Lee PI, Lu CY, Lin HC, Huang LM. Pertussis seroepidemiology in Taipei. J Formos Med Assoc. 2000;99:224–228.
   PubMed Web of Science ®Google Scholar
• Hallander HO, Andersson M, Gustafsson L, Ljungman M, Netterlid E. Seroprevalence of pertussis antitoxin (anti-PT) in Sweden before and 10 years after the introduction of a universal childhood pertussis vaccination program. APMIS. 2009;117(12):912–922. doi:10.1111/j.1600-0463.2009.02554.x.
   PubMed Web of Science ®Google Scholar
• Macina D, Evans KE. Pertussis in individuals with co-morbidities: a systematic review. Infect Dis Ther. 2021;10(3):1141–1170. doi:10.1007/s40121-021-00465-z.
   PubMed Web of Science ®Google Scholar
• Versteegh FG, Mertens PL, de Melker HE, Roord JJ, Schellekens JFP, Teunis PFM. Age-specific long-term course of IgG antibodies to pertussis toxin after symptomatic infection with bordetella pertussis. Epidemiol Infect. 2005;133(4):737–748. doi:10.1017/S0950268805003833.
   PubMed Web of Science ®Google Scholar
• Rønn PF, Dalby T, Simonsen J, Jørgensen CS, Linneberg A, Krogfelt KA. Seroepidemiology of pertussis in a cross-sectional study of an adult general population in Denmark. Epidemiol Infect. 2014;142(4):729–737. doi:10.1017/S0950268813002446.
   PubMed Web of Science ®Google Scholar
• Chen CC, Balderston MC, Krishnarajah G, Blanchette CM, Wang Y, Sun K, Buck PO. Estimated incidence of pertussis in people aged <50 years in the United States. Hum Vaccin Immunother. 2016;12:2536–2545. doi:10.1080/21645515.2016.1186313.
   PubMed Web of Science ®Google Scholar